High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up
- Conditions
- Breast Cancer Female
- Registration Number
- NCT03087409
- Lead Sponsor
- University Medical Center Groningen
- Brief Summary
Collection of follow-up data from the original trial patient cohort.
- Detailed Description
Collection of follow-up data from the original trial patient cohort by means of structured patient file abstraction, a questionnaire to the general practitioner, and registry consultations.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 885
- Enrolment in the original trial.
- None.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival 2 years Overall survival according to the definition and analysis plan of the original study
Relapse-free survival 2 years Relapse-free survival according to the definition and analysis plan of the original study
- Secondary Outcome Measures
Name Time Method Incidence of cardiovascular events 2 years Incidence of malignancies 2 years
Trial Locations
- Locations (10)
The Netherlands Cancer Institute
🇳🇱Amsterdam, Netherlands
VU University Medical Center
🇳🇱Amsterdam, Netherlands
Academic Medical Center
🇳🇱Amsterdam, Netherlands
University Medical Center Groningen
🇳🇱Groningen, Netherlands
Maastricht University Medical Center
🇳🇱Maastricht, Netherlands
Erasmus Medical Center
🇳🇱Rotterdam, Netherlands
Medisch Spectrum Twente
🇳🇱Enschede, Netherlands
Radboud University Medical Center
🇳🇱Nijmegen, Netherlands
Leiden University Medical Center
🇳🇱Leiden, Netherlands
University Medical Center Utrecht
🇳🇱Utrecht, Netherlands